We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+17.1%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$72.5B
AUM Growth
+$8.64B
Cap. Flow
-$411M
Cap. Flow %
-0.57%
Top 10 Hldgs %
21.89%
Holding
3,099
New
114
Increased
2,324
Reduced
599
Closed
47

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$108M
2
MSFT icon
Microsoft
MSFT
+$73.2M
3
AMZN icon
Amazon
AMZN
+$49.5M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$27.8M
5
META icon
Meta Platforms (Facebook)
META
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.78%
2 Financials 13.46%
3 Healthcare 13.26%
4 Consumer Discretionary 12.31%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
26
PepsiCo
PEP
$191B
$391M 0.54%
2,637,184
-40,055
-1% -$5.69M
NFLX icon
27
Netflix
NFLX
$305B
$385M 0.53%
7,120,590
-119,580
-2% -$6.06M
ABT icon
28
Abbott
ABT
$185B
$373M 0.51%
3,406,330
-17,127
-0.5% -$1.86M
WMT icon
29
Walmart Inc
WMT
$881B
$369M 0.51%
7,679,145
-378,555
-5% -$18.4M
CSCO icon
30
Cisco
CSCO
$457B
$361M 0.5%
8,077,164
+81,440
+1% +$3.35M
CRM icon
31
Salesforce
CRM
$152B
$359M 0.5%
1,614,207
-18,379
-1% -$4.47M
PFE icon
32
Pfizer
PFE
$143B
$347M 0.48%
9,430,934
-457,043
-5% -$16.8M
MRK icon
33
Merck
MRK
$316B
$344M 0.47%
4,405,242
-236,441
-5% -$18.1M
NKE icon
34
Nike
NKE
$63.3B
$339M 0.47%
2,393,503
-28,264
-1% -$3.74M
XOM icon
35
ExxonMobil
XOM
$643B
$330M 0.46%
7,998,624
-89,042
-1% -$3.34M
COST icon
36
Costco
COST
$423B
$329M 0.45%
873,131
-22,234
-2% -$8.31M
ABBV icon
37
AbbVie
ABBV
$433B
$321M 0.44%
2,993,791
-53,584
-2% -$5.15M
TMO icon
38
Thermo Fisher Scientific
TMO
$213B
$319M 0.44%
684,405
-6,331
-0.9% -$2.97M
QCOM icon
39
Qualcomm
QCOM
$159B
$319M 0.44%
2,091,336
-54,556
-3% -$7.6M
AVGO icon
40
Broadcom
AVGO
$1.87T
$311M 0.43%
7,110,030
-59,860
-0.8% -$2.33M
MCD icon
41
McDonald's
MCD
$188B
$310M 0.43%
1,446,668
-9,282
-0.6% -$2.02M
ACN icon
42
Accenture
ACN
$101B
$307M 0.42%
1,175,838
-33,845
-3% -$8.11M
TXN icon
43
Texas Instruments
TXN
$246B
$301M 0.42%
1,834,076
-18,148
-1% -$2.82M
CVX icon
44
Chevron
CVX
$385B
$299M 0.41%
3,536,421
+100,999
+3% +$8.18M
NEE icon
45
NextEra Energy
NEE
$181B
$291M 0.4%
3,772,978
-4,826
-0.1% -$361K
MDT icon
46
Medtronic
MDT
$111B
$282M 0.39%
2,409,518
+8,301
+0.3% +$914K
UNP icon
47
Union Pacific
UNP
$173B
$270M 0.37%
1,297,171
-5,306
-0.4% -$1.06M
HON icon
48
Honeywell
HON
$78.2B
$268M 0.37%
1,334,436
+3,701
+0.3% +$672K
AMGN icon
49
Amgen
AMGN
$204B
$262M 0.36%
1,139,513
-21,963
-2% -$5.06M
ORCL icon
50
Oracle
ORCL
$409B
$261M 0.36%
4,038,581
-146,731
-4% -$8.73M

Similar funds

RhumbLine Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, RhumbLine Advisers held 3,099 positions worth $72.5B, up 14% from $63.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers's Q4 2020 filing shows 114 new, 2,324 increased, 599 reduced and 47 closed positions. Its largest new stake was Apartment Income REIT Corp.: 482,605 shares worth $18.5M. The largest sale was Apple, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2020 buy was Apartment Income REIT Corp.: 482,605 shares worth $18.5M.
  • RhumbLine Advisers added most to Tesla in Q4 2020, an estimated $278M increase.
  • RhumbLine Advisers's biggest Q4 2020 reduction was Apple, cutting an estimated $108M.
  • RhumbLine Advisers fully exited Immunomedics Inc in Q4 2020, selling an estimated $20.4M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $72.5B portfolio in Q4 2020.
  • RhumbLine Advisers opened 114 new positions and closed 47 in Q4 2020.
  • RhumbLine Advisers's portfolio value rose 14% quarter-over-quarter to $72.5B.

Based on RhumbLine Advisers's 13F filing for Q4 2020, filed 10 Feb 2021.